Yu-Fu Chen
Papers
1
Total Citations
6
H-Index
1
About
Yu-Fu Chen is a leading researcher in surgical oncology and health outcomes, with a primary focus on hepatocellular carcinoma (HCC) treatment and patient quality-of-life (QOL) assessment. His most cited work, a 2022 prospective longitudinal cohort study, employed inverse probability of treatment weighting to compare long-term QOL outcomes across three surgical procedures for HCC. This landmark analysis of 520 patients provided critical insights into how different surgical approaches affect individual QOL subscales over time, identifying key predictors of post-operative well-being. With 6 citations, this study has become a foundational reference for surgeons and oncologists seeking to balance survival outcomes with patient-centered care. Chen's research uniquely bridges the gap between clinical efficacy and patient-reported outcomes, offering evidence-based guidance for treatment selection in HCC. His work is particularly valued for its rigorous methodological approach to handling selection bias in observational studies, setting a new standard for QOL research in surgical oncology. Through these contributions, Chen has established himself as a key voice in advancing personalized, holistic care for liver cancer patients.
Research Focus
Key Achievements
Top Papers
- 1